Lipocine Inc (LPCN) stock news · rev $2.0M
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
This LPCN news page leads with what Lipocine Inc filed — not a scraped headline mill.
No cached 8-K sentence for LPCN yet. We will not pad this page with generic market recap.
Latest reported LPCN revenue for 2025-12-31 was $2.0M. Net income was -$9.6M. Revenue was up 169.3% from 2023-12-31 to 2025-12-31. LPCN currently screens at market cap $19.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LPCN stock page; for the tape open the quote page.
LPCN stock news FAQ
What are LPCN's latest revenue and net income?
Latest cached Lipocine Inc (LPCN) revenue for Dec 31, 2025 was $2.0M. Net income was -$9.6M. Statements: https://lician.com/financials/lpcn
How did LPCN revenue change from the prior cached period?
Cached Lipocine Inc (LPCN) revenue was up 169.3% from -$2.9M (Dec 31, 2023) to $2.0M (Dec 31, 2025). Statements: https://lician.com/financials/lpcn
What is LPCN's market cap?
Lipocine Inc (LPCN) market cap is $19.3M on the latest cached fundamentals snapshot.
What kind of company is LPCN?
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Where is LPCN stock news listed?
Cached stock news for Lipocine Inc (LPCN) is listed at https://lician.com/news/lpcn. Filings: https://lician.com/sec/lpcn
Not investment advice.